Versameb
Latest round
- Seed
Last raised
- Oct 2019
Total raised
- $6.5M
Investors
- 1
About Versameb
Founded in 2017, Versameb AG is based in Basel, Switzerland, and specializes in RNA therapeutics.Versameb specializes in the development of next-generation RNA therapeutics aimed at addressing a variety of medical conditions. Their core product offerings include RNA-based therapies that enhance gene expression and modulation for targeted treatment of diseases. These therapeutics focus on unmet needs in rare genetic disorders, cancer, and infectious diseases.The revenue model for Versameb is largely based on strategic partnerships and collaborations with biopharmaceutical companies and research institutions. This includes fee-for-service agreements for research and development, along with milestone payments tied to the success of therapeutic candidates in clinical trials. Versameb may also employ revenue-sharing agreements for products that reach commercialization, ensuring a steady income stream as therapies gain market traction. The company aims to launch upcoming products designed to address additional medical conditions, focusing on entering new markets, specifically targeting regions in Asia and Latin America by the end of 2023.
Who invested in Versameb
1 investor across 1 round
See all investors in Versameb
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Oct 17, 2019
Amount
$6.5M
Investors
Questions about Versameb
Who invested in Versameb?
Versameb has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Versameb raised?
Versameb has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Versameb last raise money?
Versameb's most recent round on record is a Seed, in Oct 2019.
What does Versameb do?
Founded in 2017, Versameb AG is based in Basel, Switzerland, and specializes in RNA therapeutics.
Where is Versameb headquartered?
Versameb is headquartered in Basel, Switzerland.
Which VCs invest in companies like Versameb?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Versameb's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Versameb? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.